首页> 外国专利> New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents

New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents

机译:在子宫肌瘤中表达的新核酸序列和衍生的多肽,用于治疗子宫癌和鉴定治疗剂

摘要

Polypeptide sequences (I) and their fragments are new and comprise 19 open reading frame sequences given in the specification, that are highly expressed in uterine myoma. Independent claims are also included for the following: (1) 31 specific nucleic acids (II) encoding (I), comprising amino acid sequences fully defined in the specification; (2) bacterial or phage artificial chromosomes and cosmid clones containing functional genes, or the chromosome region containing them, corresponding to (II) for use as gene transfer vehicles; (3) antisense sequences to (II); (4) an expression cassette (III) comprising (II), or their fragments, plus control and regulatory sequences; (5) DNA fragments (IV) containing a gene isolated using (II); (6) host cells (V) containing (II) as a heterologous component; (7) recombinant production of (I), or their fragments, by culturing (V); (8) an antibody (VI) directed against (I), or its fragments, encoded by (II); and (9) 20 partial polypeptide sequences, all reproduced, and sequences having at least 80% homology with them.
机译:多肽序列(I)及其片段是新的,包含规范中给出的19个开放阅读框序列,这些序列在子宫肌瘤中高度表达。还包括以下方面的独立权利要求:(1)31种编码(I)的特定核酸(II),其包含说明书中完全定义的氨基酸序列; (2)对应于(II)的含有功能基因的细菌或噬菌体人工染色体和粘粒克隆,或含有它们的染色体区域,用作基因转移载体; (3)(II)的反义序列; (4)表达盒(III),其包含(II)或其片段,以及控制和调节序列; (5)DNA片段(IV),其含有用(II)分离的基因; (6)含有(II)作为异源成分的宿主细胞(V)。 (7)通过培养(V)重组生产(I)或其片段; (8)(II)编码的针对(I)的抗体(VI)或其片段; (9)全部复制的20个部分多肽序列,以及与它们具有至少80%同源性的序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号